• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Sanford Health to study alternatives to opioids

Bioengineer.org by Bioengineer.org
January 20, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Sanford Health

Sanford Health is one of three sites in the U.S. to launch a study to determine if non-opioid medications are as effective in managing pain after carpal-tunnel surgery.

Carpal tunnel syndrome is a condition causing numbness, tingling or pain in the hand and arm. The surgery to treat the condition is one of the most common surgical procedures in the U.S. This double-blind study will evaluate the effectiveness of two pain management courses: hydrocodone and acetaminophen or ibuprofen and acetaminophen.

Opioid addiction continues to be a crisis in the United States, with nearly 100 Americans dying every day from overdoses, according to the Centers for Disease Control and Prevention. More than half of all drug overdoses are related to opioids, and prescriptions for them have nearly quadrupled since 1999.

This study seeks to better understand pain management and find alternatives to prescribing opioids.

"Opioid addiction is a real concern for surgeons," said Robert Van Demark Jr., M.D., who is the principal investigator for the study and hand surgeon with Sanford Orthopedics and Sports Medicine. "We know that there's a need to both balance the pain management of our patients and to ensure we do everything we can to combat possible addictions. This study is one step we can take to better understand how to do that."

The study, which began in October, is based on work from a researcher in Canada. Health systems in Roanoke, Virginia, and Philadelphia, Pennsylvania, also are taking enrollees.

To be eligible for the study, enrollees must be 18 years or older, not be on a pain management or ibuprofen or acetaminophen regimen, have no prior addiction or substance abuse and not have cardiovascular or liver diseases. Participants will be followed for two weeks post-operation and be asked to keep a pain journal.

###

For information or to discuss qualifications, call 605-328-1368.

About Sanford Health

Sanford Health is one of the largest health care systems in the nation, with 44 hospitals and nearly 300 clinics in nine states and four countries. Headquartered in Sioux Falls, South Dakota, and serving the Upper Midwest, with nearly 1,400 physicians, Sanford Health is dedicated to several initiatives, including global children's clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases. Sanford Health has 28,000 employees, making it the largest employer in the Dakotas. Nearly $1 billion in gifts from philanthropist Denny Sanford over the past decade have transformed how Sanford Health can improve the human condition. For information, visit sanfordhealth.org.

Media Contact

Jacqueline Palfy
[email protected]
605-366-2432
@sanfordhealth

http://www.sanfordhealth.org

Share12Tweet8Share2ShareShareShare2

Related Posts

Necroptosis Creates Soluble Tissue Factor Driving Thrombosis

September 12, 2025

Terabase-Scale Long-Reads Reveal Soil Bioactive Molecules

September 12, 2025

Diverse, Lasting, and Adaptable Brain Growth Post-Preterm

September 12, 2025

Geographic Limits in Stimulus Curbed Seoul COVID-19

September 12, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    64 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Necroptosis Creates Soluble Tissue Factor Driving Thrombosis

Terabase-Scale Long-Reads Reveal Soil Bioactive Molecules

Diverse, Lasting, and Adaptable Brain Growth Post-Preterm

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.